Related Experiment Video
Updated: Jul 5, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Routine glutamic acid decarboxylase autoantibody (GADA) testing: patients' perspective
H Davies1, Sb Mannan, S Brophy
1Centre for Health Information, Research and Evaluation (CHIRAL), The School of Medicine, Swansea University, The Grove Building, Singleton Park, Swansea SA2 8PP, UK. h.davies@swansea.ac.uk
Routine testing for glutamic acid decarboxylase autoantibodies (GADA) is supported by patients newly diagnosed with Latent Autoimmune Diabetes in Adults (LADA). Patients prefer to discuss treatment options with knowledgeable healthcare professionals rather than immediately starting insulin.
Area of Science:
- Endocrinology
- Immunology
- Diabetes Research
Background:
- Latent Autoimmune Diabetes in Adults (LADA) is often misdiagnosed as type 2 diabetes (T2D) in the UK.
- GADA blood tests distinguish LADA from T2D.
- LADA patients experience slow progression to insulin dependence.
Purpose of the Study:
- To explore the views and experiences of newly diagnosed LADA patients.
- To assess patient perspectives on routine GADA testing.
- To understand patient information needs and self-management influences.
Main Methods:
- Qualitative semi-structured interviews with ten newly diagnosed LADA patients.
- Analysis of patient views and experiences using a constant comparative method.
Main Results:
- Patients supported routine GADA testing for accurate diagnosis and treatment consideration.
- Participants preferred using future HbA1c levels and physician advice for insulin treatment decisions.
- Some patients struggled to differentiate diabetes types and required further discussion and information.
Conclusions:
- Support for routine GADA testing in all diabetes patients.
- Preference for discussing LADA treatment options with informed healthcare professionals before initiating insulin.
- Need for clear communication and additional information for LADA patients.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Type I Diabetes I: Introduction
Myasthenia Gravis ll: Pathophysiology